ArticleJournal of inflammation research2025
Correlation Between Red Blood Cell Distribution Width to Albumin Ratio and Cardiovascular Events in Maintenance Hemodialysis Patients.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the correlation between red blood cell distribution width to albumin ratio (RAR) and cardiovascular events (CVEs) in maintenance hemodialysis (MHD) patients. Methods: Clinical data were retrospectively collected from MHD patients in Tongren Hospital, Shanghai Jiao Tong University School of Medicine from January 1, 2017 to May 31, 2024. The prognostic endpoints in this study were CVEs. Kaplan-Meier survival curve, Cox regression model, restricted cubic spline analyses and subgroup analysis were used to analyze the independent relationship between RAR and CVEs. Results: A total of 237 MHD patients were included. The median follow-up was 22 (6, 45) months, and CVEs occurred in 100 patients (100/237, 42.2%). The population was divided into Tertile1, 2, and 3 according to the tertiles of baseline RAR levels. Kaplan-Meier survival curve showed a significant difference in the cumulative survival free of CVEs among the tertiles ( Conclusion: Elevated RAR is an independent risk factor for CVEs in MHD patients, and RAR may be helpful for early detection of CVEs risk in MHD patients, although sex differences should be taken in account.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.